Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000424048 | SCV000535971 | pathogenic | not provided | 2017-01-23 | criteria provided, single submitter | clinical testing | The S118X variant in the HNRNPU gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The S118X variant was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret S118X as a pathogenic variant. |
Genome |
RCV001824767 | SCV002074696 | not provided | Developmental and epileptic encephalopathy, 1 | no assertion provided | phenotyping only | Variant interpreted as Pathogenic and reported on 01-30-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |